Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy

BACKGROUND: Nevirapine has been used as antiretroviral agent since early ‘90. Although nevirapine is not currently recommended in initial anti-HIV regimens, its use remains consistent in a certain number of HIV-1-positive subjects. Thus, our aim was to determine clinical and genetic factors involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Giacomelli, Andrea, Riva, Agostino, Falvella, Felicia Stefania, Oreni, Maria Letizia, Cattaneo, Dario, Cheli, Stefania, Renisi, Giulia, Di Cristo, Valentina, Lupo, Angelica, Clementi, Emilio, Rusconi, Stefano, Galli, Massimo, Ridolfo, Anna Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233541/
https://www.ncbi.nlm.nih.gov/pubmed/30419834
http://dx.doi.org/10.1186/s12879-018-3462-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233541/
https://www.ncbi.nlm.nih.gov/pubmed/30419834
http://dx.doi.org/10.1186/s12879-018-3462-5

Ejemplares similares